Literature DB >> 9578553

Interfacial recognition by bee venom phospholipase A2: insights into nonelectrostatic molecular determinants by charge reversal mutagenesis.

F Ghomashchi1, Y Lin, M S Hixon, B Z Yu, R Annand, M K Jain, M H Gelb.   

Abstract

The basis for tight binding of bee venom phospholipase A2 (bvPLA2) to anionic versus zwitterionic phospholipid interfaces is explored by charge reversal mutagenesis of basic residues (lysines/arginines to glutamates) on the putative membrane binding surface. Single-site mutants and, surprisingly, multisite mutants (2-5 of the 6 basic residues mutated) are fully functional on anionic vesicles. Mutants bind tightly to anionic vesicles, and active-site substrate and Ca2+ binding are not impaired. Multisite mutants undergo intervesicle exchange slightly faster than wild type, especially in the presence of salt. It is estimated that electrostatic contribution to interfacial binding is modest, perhaps 2-3 kcal/mol of the estimated 15 kcal/mol. Elution properties of bvPLA2 from HPLC columns containing solid phases of tightly packed monolayers of phosphocholine amphiphiles suggest that ionic effects provide a modest portion of the interfacial binding energy and that this contribution decreases as the number of cationic residues mutated is increased. These results are consistent with the observation that Gila monster venom PLA2 (Pa2), which is homologous to bvPLA2, has high activity on anionic vesicles despite the fact that it has only a single basic residue on its putative interfacial recognition face. Results with bvPLA2 mutants show that manoalogue and 12-epi-scalaradial inactivate bvPLA2 by modification of K94. Also, deletion of the large beta-loop (residues 99-118) is without consequence for interfacial binding and catalysis of bvPLA2. All together, the preferential binding of bvPLA2 to anionic vesicles versus phosphatidylcholine vesicles is mainly due to factors other than electrostatics. Therefore hydrogen-bonding and hydrophobic interactions must provide a major portion of the interfacial binding energy, and this is consistent with recent spectroscopic studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9578553     DOI: 10.1021/bi972525i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Ubiquitin activates patatin-like phospholipases from multiple bacterial species.

Authors:  David M Anderson; Hiromi Sato; Aaron T Dirck; Jimmy B Feix; Dara W Frank
Journal:  J Bacteriol       Date:  2014-11-17       Impact factor: 3.490

2.  Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule.

Authors:  Pedro A Sánchez-Murcia; Alberto Mills; Álvaro Cortés-Cabrera; Federico Gago
Journal:  J Comput Aided Mol Des       Date:  2019-05-31       Impact factor: 3.686

3.  Structural analysis of secretory phospholipase A2 from Clonorchis sinensis: therapeutic implications for hepatic fibrosis.

Authors:  Gururao Hariprasad; Punit Kaur; Alagiri Srinivasan; Tej Pal Singh; Manoj Kumar
Journal:  J Mol Model       Date:  2012-01-04       Impact factor: 1.810

4.  Phenylalanine-24 in the N-terminal region of ammodytoxins is important for both enzymic activity and presynaptic toxicity.

Authors:  Toni Petan; Igor Krizaj; Franc Gubensek; Joze Pungercar
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

5.  Modulation of the activity of secretory phospholipase A2 by antimicrobial peptides.

Authors:  Hongxia Zhao; Paavo K J Kinnunen
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

6.  Amyloid-type fiber formation in control of enzyme action: interfacial activation of phospholipase A2.

Authors:  Christian Code; Yegor Domanov; Arimatti Jutila; Paavo K J Kinnunen
Journal:  Biophys J       Date:  2008-03-13       Impact factor: 4.033

7.  Discovery of novel membrane binding structures and functions.

Authors:  Irina Kufareva; Marc Lenoir; Felician Dancea; Pooja Sridhar; Eugene Raush; Christin Bissig; Jean Gruenberg; Ruben Abagyan; Michael Overduin
Journal:  Biochem Cell Biol       Date:  2014-09-18       Impact factor: 3.626

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.